Diabetic Neuropathy Market Segmentation:
Disorder Segment Analysis
The global diabetic neuropathy market is segmented and analyzed for demand and supply by disorder into peripheral, autonomic, proximal, and focal neuropathy. Out of which, the peripheral neuropathy segment is anticipated to hold the largest diabetic neuropathy market size by the end of 2035 on account of rising cases of nerve pain or traumatic injuries, infections, and metabolic problems causing nerve damage that leads to peripheral neuropathy. More than 62,000 traumatic brain injury-related deaths occurred in the U.S. in 2020, accounting for about 170 deaths per day. Nerve damage can be caused by various incidents that occur in daily life, such as road accidents, increasing stress, anxiety, depression, surgery, cancer, infections, alcohol consumption, genetic neurological conditions, diabetes, and falling during sports or in any situation. People should look for symptoms such as numbness, loss of coordination, muscle fatigue, unable to stand or walk properly, muscle spasms, pain, and a buzzing sensation such as electrical shock.
Treatment Segment Analysis
The global diabetic neuropathy market is also segmented and analyzed for demand and supply by treatment into drugs, transcutaneous electrical nerve stimulation (TENS), and others. Amongst these three segments, the drugs segment is expected to garner a significant share. Patients suffering from mild to severe pain or inflammation use various kinds of drugs, and non-steroidal drugs (NSAIDs) are one of the most common drugs. The increasing use of these drugs across the globe impacts the growth of the diabetic neuropathy market segment as per the analysis during the forecast period. NSAIDs are used to prevent the release of certain chemicals in the body that cause pain. These are mainly used in arthritis pain caused owing to bone deterioration mostly in old age people. These are also prescribed to decrease migraines, tooth pain, and high fevers such as the flu where body pains are common symptoms. It belongs to the class of painkillers and is used as an analgesic and antipyretic. During COVID-19 in 2019, NSAIDs are used by about 20% of patients to reduce mild fever and body pains which are believed to provide a survival benefit to patients in China.
Our in-depth analysis of the global diabetic neuropathy market includes the following segments:
|
By Disorder |
|
|
By Treatment |
|
|
By End-User |
|
